Experimental Alzheimer’s Drug Slows Thinking Declines in Late-Stage Trial
MONDAY, July 17, 2023 (HealthDay News) — Another experimental drug meant to slow the damage of Alzheimer’s appears poised to join a growing arsenal of new treatments for this memory-robbing disease. In research published online Monday in the Journal of the American Medical Association and presented simultaneously at the Alzheimer’sContinue Reading